Effects of Inhaled Corticosteroids on Mortality and Hospitalisation in Elderly Asthma and Chronic Obstructive Pulmonary Disease PatientsAppraising the Evidence

被引：0
|
作者：
Jordana K. Schmier
Michael T. Halpern
Mechelle L. Jones
机构：
[1] Exponent Inc.,
来源：
Drugs & Aging | 2005年 / 22卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Fluticasone Propionate; Salmeterol; Chronic Obstructive Pulmonary Disease Exacerbation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Asthma and chronic obstructive pulmonary disease (COPD) are common conditions that have substantial effects on daily functioning and medical resource utilisation. In elderly populations, the use of inhaled corticosteroids (ICS) as a mainstay of treatment in asthma has long been accepted whereas the appropriateness and extent of use of ICS in COPD is not as clear. This paper reviews data associated with ICS treatment in the elderly, specifically characteristics of ICS users, rates of adherence, hospitalisation and mortality associated with ICS treatment.
引用
收藏
页码：717 / 729
页数：12
相关论文
共 50 条
  • [41] Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study
    Shin, Jiyoung
    Park, Sojung
    Lee, Ji-Young
    Lee, Jin Hwa
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
    Marc Miravitlles
    Borja G. Cosío
    Aurelio Arnedillo
    Myriam Calle
    Bernardino Alcázar-Navarrete
    Cruz González
    Cristóbal Esteban
    Juan Antonio Trigueros
    José Miguel Rodríguez González-Moro
    José Antonio Quintano Jiménez
    Adolfo Baloira
    Respiratory Research, 18
  • [43] Current opinions on the role of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease
    Lassan, S.
    Tisonova, J.
    Lassanova, M.
    Wawruch, M.
    Kristova, V
    Kriska, M.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2007, 108 (02): : 83 - 88
  • [44] Inhaled corticosteroids and survival in chronic obstructive pulmonary disease: does the dose matter?
    Sin, DD
    Man, SFP
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) : 260 - 266
  • [45] Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease
    Bourbeau, J
    Rouleau, MY
    Boucher, S
    THORAX, 1998, 53 (06) : 477 - 482
  • [46] Management of Asthma and Chronic Obstructive Pulmonary Disease with Combination Inhaled Corticosteroids and Long-Acting β-Agonists: A Review of Comparative Effectiveness Research
    Douglas W. Mapel
    Melissa H. Roberts
    Drugs, 2014, 74 : 737 - 755
  • [47] Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
    Sonnex, Kimberley
    Alleemudder, Hanna
    Knaggs, Roger
    BMJ OPEN, 2020, 10 (04):
  • [48] Inhaled corticosteroids in chronic obstructive pulmonary disease: How significant is the risk of pneumonia and should it impact use of inhaled corticosteroids?
    Cavallazzi R.
    Singh S.
    Current Infectious Disease Reports, 2011, 13 (3) : 296 - 301
  • [49] Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease
    Parimon, Tanyalak
    Chien, Jason W.
    Bryson, Chris L.
    McDonell, Mary B.
    Udris, Edmunds M.
    Au, David H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (07) : 712 - 719
  • [50] Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: A systematic review and a meta-analysis
    Gan W.Q.
    Man S.F.P.
    Sin D.D.
    BMC Pulmonary Medicine, 5 (1)
12345